.After introducing a period 3 launch based on positive midstage results, iTeos and also GSK are fina...
.The FDA needs to be extra available and also collaborative to release a surge in approvals of uncom...
.It is actually an uncommonly occupied Friday for biotech IPOs, with Zenas BioPharma, MBX as well as...
.Atea Pharmaceuticals' antiviral has actually failed one more COVID-19 trial, however the biotech st...
.Neurocrine Biosciences' schizophrenia plan pivot has actually stopped working. The biotech was inca...
.Sanofi has actually created an overdue access to the radioligand event, paying for 100 thousand eur...
.After F2G's first attempt to get a new course of antifungal to market was derailed due to the FDA, ...
.Moderna has pledged to cut R&D spending by $1.1 billion through 2027. The decision to retract th...
.Merely 4 months after Sanofi bet $80 thousand in ahead of time cash on Fulcrum Therapeutics' losmap...
.Cancer provider Oncternal Therapeutics is actually folding all its clinical trials as well as layin...